Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 1997

View Archived Issues

Tsumura describes agents for dermatitis

Chymase inhibitors from Green Cross

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Rockefeller University discloses antibiotic peptides

Merck describes improved chemotherapeutic agents

Il Yang develops antitumor/immunostimulating proteoglycan

Antiallergic/antiinflammatory agents from Senju

Japanese researchers describe triazole antifungals

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Legionella vaccine described by U.S. researchers

Promising new imaging agent for CNS disorders

Potential anticonvulsant described by CoCensys

Follow-up data reported for Amelorad

First launch for SCLC imaging agent

Promising data reported for fomivirsen

Isis updates activities related to ISIS-2302

Isis previews antisense anticancer program

Another Isis antisense compound to enter clinic

Progress in Bone Care's vitamin D pipeline

Zynaxis sells drug delivery technology

Alza signs licensing agreements for transdermal testesterone products

CEAPRO receives patent coverage for potential vaccine adjuvants

Cypress awarded grant for research related to its PROSORBA Column

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

NIH funds development of antiplatelet agents from Cypress/PRP

RPR's docetaxel now approved in 49 countries

Pegasus completes acquisition

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...